Leerink Partnrs Weighs in on REGENXBIO Inc.'s Q2 2024 Earnings (NASDAQ:RGNX)

REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2024 earnings per share (EPS) estimates for shares of REGENXBIO in a research report issued to clients and investors on Wednesday, May 8th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will earn ($1.19) per share for […]

Related Keywords

Canada ,United States ,China ,Stifel Nicolaus ,Leerink Partnrs ,Steve Pakola ,Allspring Global Investments Holdings ,Headlands Technologies ,Securities Exchange Commission ,China Universal Asset Management Co ,Regenxbio Inc ,Financial Services Group Inc ,Technology Platform ,Royal Bank ,Annandale Capital ,Nasdaq ,Free Report ,Get Free Report ,Exchange Commission ,Services Group ,Global Investments Holdings ,China Universal Asset Management ,Universal Asset Management ,